Navigation Links
PDL BioPharma Announces Fourth Quarter and Full Year 2012 Financial Results
Date:3/1/2013

INCLINE VILLAGE, Nev., March 1, 2013 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the fourth quarter and full year ended December 31, 2012.

(Logo:  http://photos.prnewswire.com/prnh/20110822/SF55808LOGO)

Total revenues in 2012 were $374.5 million, compared to $362.0 million in 2011, with royalty revenues increasing seven percent over full year 2011. For the fourth quarter of 2012, total revenues were $86.0 million, compared to $72.8 million in the fourth quarter of 2011.

Royalty revenues for the fourth quarter of 2012 are based on third quarter product sales by PDL's licensees. The fourth quarter 2012 revenue growth was primarily driven by increased royalties from third quarter 2012 sales of Herceptin® and Avastin®, which are marketed by Genentech and Roche.  Royalty revenue for the fourth quarter and 2012 are net of payments made under our February 2011 settlement agreement with Novartis Pharma AG.

Operating expenses in 2012 were $25.5 million, compared with $18.3 million in 2011. For the fourth quarter of 2012, general and administrative expenses were $7.7 million compared with $4.8 million for the same period of 2011.

Net income in 2012 was $211.7 million, or $1.45 per diluted share as compared with net income of $199.4 million in 2011 or $1.15 per diluted share. Net income for the fourth quarter of 2012 was $49.4 million or $0.34 per diluted share as compared with net income of $38.9 million or $0.24 per diluted share for the same period of 2011.

Net cash provided by operating activities in 2012 was $210.2 million, compared with $169.8 million in 2011. At December 31, 2012, PDL had cash, cash equivalents and investments of $148.7 million, compared with $227.9 million at
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Biopharma M&A Trends Hold Steady, But Deals Declined in 2011
2. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
3. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
4. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
5. Genesis Biopharma Announces Termination of Previously Announced Proposed Public Offering
6. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
7. S1 Biopharma Expands Focus to Include Male Sexual Health
8. New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
9. Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
10. Cell Therapeutics Aequus BioPharma Validates its Proprietary GlycoPolymer Technology for the Extension of the Half-life of Therapeutic Protein Drugs
11. Galena Biopharma, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... May 5, 2015  Image Stream Medical, a leader ... with MedAssets, one of the largest group purchasing organizations, ... States.  Under terms of the three-year agreement, Image Stream,s ... will be made available to MedAssets members beginning on ... Image Stream Medical CEO Eddie Mitchell said, ...
(Date:5/5/2015)... 2015 Faced with fast economy and population growth, ... China,s medical device industry has been growing ... demands have been Beijing , ... first-tier cities. However, the entry of a large number of ... markets in first-tier cities increasingly saturated. How do medical device ...
(Date:5/5/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/f27x5g/clinical ) ... Laboratory,Molecular Diagnostics and Genomic Testing Services Market Trends ... Africa and Middle East Version" report to ... keeps on growing. Clinical laboratory testing is positioned ... especially genomics. A range of dynamic trends are ...
Breaking Medicine Technology:Image Stream Medical Announces Agreement with MedAssets 2MEDITEXPO JIANGSU 2015 is to Help Medical Device Companies Explore Business Opportunities in Wider Markets 2MEDITEXPO JIANGSU 2015 is to Help Medical Device Companies Explore Business Opportunities in Wider Markets 3MEDITEXPO JIANGSU 2015 is to Help Medical Device Companies Explore Business Opportunities in Wider Markets 4Latin America, Africa and Middle East Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market 2015-2019 2
... Dey Pharma, L.P. today announced that it has ... specialty pharma company headquartered in Sweden, for the exclusive ... Europe. EpiPen Auto-Injector is used for emergency treatment of ... within a couple of minutes, and may be life-threatening. ...
... BURLINGTON, Mass., Dec. 23, 2010 Decision Resources, one of ... healthcare issues, finds that 60 percent of surveyed type 2 ... they would request that their doctor switch them to a ... The new Patient Forum report entitled ...
Cached Medicine Technology:Mylan's Dey Pharma Partners with Meda to Market EpiPen® Auto-Injector in Europe 2Mylan's Dey Pharma Partners with Meda to Market EpiPen® Auto-Injector in Europe 3Sixty Percent of Surveyed Type 2 Diabetes Patients in the U.S. Who Use Insulin Indicate They Would Request a Switch to a Less Expensive Biosimilar Insulin if Such an Agent Became Available 2
(Date:5/5/2015)... (PRWEB) May 05, 2015 Baptist Medical ... Commission on Cancer (CoC) of the American College of ... program must meet more than 30 Commission on Cancer ... a survey process, and maintain levels of excellence in ... When patients choose to seek care locally at a ...
(Date:5/5/2015)... Georgia (PRWEB) May 05, 2015 ... of Victoria BC announced the Skedans Sensor Collaboration ... platform, for mobile and web app developers, provides tooling ... airborne and mobile sensors. , The Skedans Sensor Collaboration ... the intersection of the Internet of Things, Web Real ...
(Date:5/5/2015)... 2015 MAP Health Management, LLC, a ... management for addiction treatment facilities, announced today that Jimmy ... Business Development. Mr. Mooney, who has more than 35 ... be responsible for developing new strategic partnerships with substance ... products and new initiatives. , Prior to joining MAP, ...
(Date:5/5/2015)... Grand Bahama (PRWEB) May 05, 2015 ... its Orthopedic Lifestyle Report today. The study was conducted ... conditions such as osteoarthritis and sports-related injuries ... pain and stiffness was the most prevalent symptom reported ... functionality such as walking, standing and bending over. Over ...
(Date:5/5/2015)... 05, 2015 On April 8th, 2015, ... CA, Choices Recovery sponsored Durkin Entertainment’s “RockNRolla” EcoLuxe Lounge, ... producer of sustainable product placement in TV and film. ... top providers of ecologically sound and socially conscious products ... carpet event that makes appearances at various awards ceremonies ...
Breaking Medicine News(10 mins):Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 2Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 4Health News:Skedans Systems Announces Skedans Sensor Collaboration Platform at AUVSI's Unmanned Systems 2015 in Atlanta 2Health News:Jimmy Mooney, an Addiction Treatment Veteran, Named Vice President of Business Development at MAP Health Management, LLC 2Health News:Okyanos Study Finds Orthopedic Patients Plagued with Pain 2Health News:Okyanos Study Finds Orthopedic Patients Plagued with Pain 3Health News:Choices Recovery Mishawaka Talks About Overcoming Adversity with Actor Matthew Ziff at the “RockNRolla Movie Awards” EcoLuxe Lounge 2
... said Wednesday it had tied up with private healthcare ... 100 cities. // , ,Under the agreement, Apollo ... WebWorld cyber stores in 105 cities to offer high-quality ... to the Apollo Telemedicine Networking Foundation (ATNF), said a ...
... of Michigan Kellogg Eye Center had developed a rapid ... ,Scientists have created a first-of-its-kind test on a // ... for patients with the blinding disease known as retinitis ... reliable and cost-effective., ,In the new issue of ...
... had been linked to health hazards before but a ... deaths caused by air pollution. The study shows that ... times greater than earlier believed., ,The study appears ... researchers of the University of Southern California, among the ...
... always been stated time and again that smoking is injurious ... respiratory system. The effects of smoking may be understood by ... // lungs., ,Monoamine oxidase A (MAOA) is important in ... blood pressure. In a new study, researchers at the National ...
... of elderly people may be a long way off, but ... and slow the crippling illness, say experts.//, ,"Not many ... process of ageing with phases of forgetfulness and slowing down ... slowly goes blank," N.M. Narula, president of the Delhi chapter ...
... cancer is the most common cancer affecting men and occurs ... Men above the age of 50 years should undergo the ... // Prostate Specific Antigen, by monitoring the levels of PSA ... of the disease should begin regular prostate screening exams at ...
Cached Medicine News:Health News:Active Lifestyle Helps To Slowdown Illness In Alzheimer's Patients 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: